4//SEC Filing
Dulac Edward J III 4
Accession 0000950170-24-025992
CIK 0001434316other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:24 PM ET
Size
4.6 KB
Accession
0000950170-24-025992
Insider Transaction Report
Form 4
Dulac Edward J III
Chief Financial Officer
Transactions
- Sale
Common Stock
2024-03-04$7.77/sh−2,447$19,013→ 101,479 total
Footnotes (1)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 5, 2023.
Documents
Issuer
FATE THERAPEUTICS INC
CIK 0001434316
Entity typeother
Related Parties
1- filerCIK 0001821530
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 4:24 PM ET
- Size
- 4.6 KB